Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Business
Johnson Matthey has acquired X-Zyme, a Düsseldorf, Germany-based provider of enzymes, particularly oxidoreductases, and chiral intermediates. X-Zyme is a 2001 spin-off from Heinrich Heine University’s Institute of Molecular Enzyme Technology. It will become part of Johnson Matthey’s catalysis and chiral technologies business, established to provide catalysis to the pharmaceutical, fine chemicals, and agrochemical markets. More than 20% of pharmaceutical intermediates contain chiral alcohols, according to Johnson Matthey.
This article has been sent to the following recipient: